论文部分内容阅读
乳腺癌对化放疗敏感,常规的综合治疗可使相当部分患者长期无病生存,但对复发和高危乳腺癌患者效果不佳。造血干细胞移植(HSCT)技术为晚期、高危乳腺癌的治疗带来了新的选择。
Breast cancer is sensitive to chemoradiotherapy. Conventional comprehensive treatment can make long-term disease-free survival of a considerable part of patients, but its effect on patients with recurrent and high-risk breast cancer is not good. Hematopoietic stem cell transplantation (HSCT) technology brings new options for the treatment of advanced, high-risk breast cancer.